H. S. Semiz Et Al. , "CD47 (don't eat me signal) expression levels and its relationship with clinicopathologic features in early-stage prostate carcinoma," PROSTATE , vol.82, no.16, pp.1564-1571, 2022
Semiz, H. S. Et Al. 2022. CD47 (don't eat me signal) expression levels and its relationship with clinicopathologic features in early-stage prostate carcinoma. PROSTATE , vol.82, no.16 , 1564-1571.
Semiz, H. S., Kucuk, U., Kisa, E., Keskinkılıç, M., Suyun, D. E., Arayici, M. E., ... Atag, E.(2022). CD47 (don't eat me signal) expression levels and its relationship with clinicopathologic features in early-stage prostate carcinoma. PROSTATE , vol.82, no.16, 1564-1571.
Semiz, HÜSEYİN Et Al. "CD47 (don't eat me signal) expression levels and its relationship with clinicopathologic features in early-stage prostate carcinoma," PROSTATE , vol.82, no.16, 1564-1571, 2022
Semiz, HÜSEYİN S. Et Al. "CD47 (don't eat me signal) expression levels and its relationship with clinicopathologic features in early-stage prostate carcinoma." PROSTATE , vol.82, no.16, pp.1564-1571, 2022
Semiz, H. S. Et Al. (2022) . "CD47 (don't eat me signal) expression levels and its relationship with clinicopathologic features in early-stage prostate carcinoma." PROSTATE , vol.82, no.16, pp.1564-1571.
@article{article, author={HÜSEYİN SALİH SEMİZ Et Al. }, title={CD47 (don't eat me signal) expression levels and its relationship with clinicopathologic features in early-stage prostate carcinoma}, journal={PROSTATE}, year=2022, pages={1564-1571} }